Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment

von Sarnowski, 2013, Prevalence of stenoses and occlusions of brain-supplying arteries in young stroke patients, Neurology, 80, 1287, 10.1212/WNL.0b013e31828ab2ed Wang, 2014, Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese intracranial atherosclerosis (CICAS) study, Stroke, 45, 663, 10.1161/STROKEAHA.113.003508 Kim, 2010, Increasing frequency and burden of cerebral artery atherosclerosis in Korean stroke patients, Yonsei Med J, 51, 318, 10.3349/ymj.2010.51.3.318 Lange, 2018, Stroke recurrence in the different subtypes of ischemic stroke: the importance of the intracranial disease, Arq Neuropsiquiatr, 76, 649, 10.1590/0004-282x20180095 Wabnitz, 2019, Hemodynamic markers in the anterior circulation as predictors of recurrent stroke in patients with intracranial stenosis, Stroke, 50, 143, 10.1161/STROKEAHA.118.020840 Dearborn, 2017, Intracranial atherosclerosis and dementia: the atherosclerosis risk in communities (ARIC) study, Neurology, 88, 1556, 10.1212/WNL.0000000000003837 Turan, 2017, Relationship between risk factor control and vascular events in the SAMMPRIS trial, Neurology, 88, 379, 10.1212/WNL.0000000000003534 Sylaja, 2018, Ischemic stroke profile, risk factors, and outcomes in India: the Indo-US collaborative stroke project, Stroke, 49, 219, 10.1161/STROKEAHA.117.018700 Bang, 2009, Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: data from a diverse race-ethnic group, J Neurol Sci, 284, 40, 10.1016/j.jns.2009.03.033 Lim, 2021, The effect of intracranial stenosis on cognitive decline in a memory clinic cohort, Eur J Neurol, 28, 1829, 10.1111/ene.14788 Wong, 2010, Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial, Lancet Neurol, 9, 489, 10.1016/S1474-4422(10)70060-0 Shu, 2021, Metabolic syndrome, intracranial arterial stenosis and cerebral small vessel disease in community-dwelling populations, Stroke Vasc Neurol, 6, 589, 10.1136/svn-2020-000813 Hurford, 2020, Prognosis of asymptomatic intracranial stenosis in patients with transient ischemic attack and minor stroke, JAMA Neurol, 77, 947, 10.1001/jamaneurol.2020.1326 Gutierrez, 2020, Classification of covert brain infarct subtype and risk of death and vascular events, Stroke, 51, 90, 10.1161/STROKEAHA.119.026068 Sharma, 2012, Stroke risk factors and outcomes among various Asian ethnic groups in Singapore, J Stroke Cerebrovasc Dis, 21, 299, 10.1016/j.jstrokecerebrovasdis.2010.08.010 Planas-Ballvé, 2019, The Barcelona-asymptomatic intracranial atherosclerosis study: subclinical intracranial atherosclerosis as predictor of long-term vascular events, Atherosclerosis, 282, 132, 10.1016/j.atherosclerosis.2019.01.022 Matsui, 2016, A prospective study of asymptomatic intracranial atherosclerotic stenosis in neurologically normal volunteers in a Japanese cohort, Front Neurol, 7, 39, 10.3389/fneur.2016.00039 Suri, 2016, Prevalence of intracranial atherosclerotic stenosis using high-resolution magnetic resonance angiography in the general population: the atherosclerosis risk in communities study, Stroke, 47, 1187, 10.1161/STROKEAHA.115.011292 Gutierrez, 2021, determinants and outcomes of asymptomatic intracranial atherosclerotic stenosis, J Am Coll Cardiol, 78, 562, 10.1016/j.jacc.2021.05.041 Waddy, 2009, Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis, Stroke, 40, 719, 10.1161/STROKEAHA.108.526624 Bang, 2018, Intracranial large artery disease of non-atherosclerotic origin: recent progress and clinical implications, J Stroke, 20, 208, 10.5853/jos.2018.00150 Sacco, 1995, Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study, Stroke, 26, 14, 10.1161/01.STR.26.1.14 Chaturvedi, 2007, Risk factor status and vascular events in patients with symptomatic intracranial stenosis, Neurology, 69, 2063, 10.1212/01.wnl.0000279338.18776.26 Turan, 2010, Risk factors associated with severity and location of intracranial arterial stenosis, Stroke, 41, 1636, 10.1161/STROKEAHA.110.584672 Turan, 2007, Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis, Circulation, 115, 2969, 10.1161/CIRCULATIONAHA.106.622464 Derdeyn, 2014, Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial, Lancet, 383, 333, 10.1016/S0140-6736(13)62038-3 Chimowitz, 2005, Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis, N Engl J Med, 352, 1305, 10.1056/NEJMoa043033 Kasner, 2006, Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis, Circulation, 113, 555, 10.1161/CIRCULATIONAHA.105.578229 Hurford, 2020, Prevalence, predictors, and prognosis of symptomatic intracranial stenosis in patients with transient ischaemic attack or minor stroke: a population-based cohort study, Lancet Neurol, 19, 413, 10.1016/S1474-4422(20)30079-X Zaidat, 2015, Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial, JAMA, 313, 1240, 10.1001/jama.2015.1693 Gutierrez, 2021, Determinants and outcomes of asymptomatic intracranial atherosclerotic stenosis, J Am Coll Cardiol, 78, 562, 10.1016/j.jacc.2021.05.041 Williamson, 2019, Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial, JAMA, 321, 553, 10.1001/jama.2018.21442 Gottesman, 2020, Association of intracranial atherosclerotic disease with brain β-amyloid deposition: secondary analysis of the ARIC Study, JAMA Neurol, 77, 350, 10.1001/jamaneurol.2019.4339 Virmani, 2000, Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions, Arterioscler Thromb Vasc Biol, 20, 1262, 10.1161/01.ATV.20.5.1262 Glagov, 1987, Compensatory enlargement of human atherosclerotic coronary arteries, N Engl J Med, 316, 1371, 10.1056/NEJM198705283162204 Pasterkamp, 1997, The impact of atherosclerotic arterial remodeling on percentage of luminal stenosis varies widely within the arterial system: a postmortem study, Arterioscler Thromb Vasc Biol, 17, 3057, 10.1161/01.ATV.17.11.3057 Gutierrez, 2014, Determinants of cerebrovascular remodeling: do large brain arteries accommodate stenosis?, Atherosclerosis, 235, 371, 10.1016/j.atherosclerosis.2014.05.925 Ryoo, 2015, Differential vascular pathophysiologic types of intracranial atherosclerotic stroke: a high-resolution wall magnetic resonance imaging study, Stroke, 46, 2815, 10.1161/STROKEAHA.115.010894 Prabhakaran, 2021, Predictors of early infarct recurrence in patients with symptomatic intracranial atherosclerotic disease, Stroke, 52, 1961, 10.1161/STROKEAHA.120.032676 Amin-Hanjani, 2015, Hemodynamic features of symptomatic vertebrobasilar disease, Stroke, 46, 1850, 10.1161/STROKEAHA.115.009215 Khan, 2012, Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke, Stroke, 43, 1230, 10.1161/STROKEAHA.111.641696 Gutierrez, 2019, Brain arterial dilatation and the risk of Alzheimer's disease, Alzheimers Dement, 15, 666, 10.1016/j.jalz.2018.12.018 Feldmann, 2007, The stroke outcomes and neuroimaging of intracranial atherosclerosis (SONIA) trial, Neurology, 68, 2099, 10.1212/01.wnl.0000261488.05906.c1 Sarikaya, 2021, Comparison of time-of-flight MR angiography and intracranial vessel wall MRI for luminal measurements relative to CT angiography, Br J Radiol, 94, 10.1259/bjr.20200743 Kleindorfer, 2021, 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association, Stroke, 52, e364, 10.1161/STR.0000000000000375 Yang, 2016, Postmortem study of validation of low signal on fat-suppressed T1-weighted magnetic resonance imaging as marker of lipid core in middle cerebral artery atherosclerosis, Stroke, 47, 2299, 10.1161/STROKEAHA.116.013398 Mandell, 2012, Vessel wall MRI to differentiate between reversible cerebral vasoconstriction syndrome and central nervous system vasculitis: preliminary results, Stroke, 43, 860, 10.1161/STROKEAHA.111.626184 Reiffel, 2017, Time in the therapeutic range for patients taking warfarin in clinical trials: useful, but also misleading, misused, and overinterpreted, Circulation, 135, 1475, 10.1161/CIRCULATIONAHA.116.026854 Patrono, 1994, Aspirin as an antiplatelet drug, N Engl J Med, 330, 1287, 10.1056/NEJM199405053301808 Gurbel, 2007, Evaluation of dose-related effects of aspirin on platelet function: results from the aspirin-induced platelet effect (ASPECT) study, Circulation, 115, 3156, 10.1161/CIRCULATIONAHA.106.675587 Hirsh, 1992, Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effects, Chest, 102, 327S Mehta, 2010, Dose comparisons of clopidogrel and aspirin in acute coronary syndromes, N Engl J Med, 363, 930, 10.1056/NEJMoa0909475 Jones, 2021, Comparative effectiveness of aspirin dosing in cardiovascular disease, N Engl J Med, 384, 1981, 10.1056/NEJMoa2102137 Wang, 2013, Clopidogrel with aspirin in acute minor stroke or transient ischemic attack, N Engl J Med, 369, 11, 10.1056/NEJMoa1215340 Johnston, 2018, Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA, N Engl J Med, 379, 215, 10.1056/NEJMoa1800410 Liu, 2015, Dual antiplatelet therapy in stroke and ICAS: subgroup analysis of CHANCE, Neurology, 85, 1154, 10.1212/WNL.0000000000001972 Chimowitz, 2011, Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial, J Stroke Cerebrovasc Dis, 20, 357, 10.1016/j.jstrokecerebrovasdis.2011.05.001 Abdul Rahman, 2020, Dual antiplatelet therapy beyond 90 days in symptomatic intracranial stenosis in the SAMMPRIS trial, J Stroke Cerebrovasc Dis, 29, 10.1016/j.jstrokecerebrovasdis.2020.105254 Cavallari, 2011, Role of cytochrome P450 genotype in the steps toward personalized drug therapy, Pharm Genomics Pers Med, 4, 123 Wang, 2016, Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack, JAMA, 316, 70, 10.1001/jama.2016.8662 Meschia, 2020, Efficacy of clopidogrel for prevention of stroke based on CYP2C19 allele status in the POINT trial, Stroke, 51, 2058, 10.1161/STROKEAHA.119.028713 Tanaka, 2019, Association of CYP2C19 polymorphisms with clopidogrel reactivity and clinical outcomes in chronic ischemic stroke, Circ J, 83, 1385, 10.1253/circj.CJ-18-1386 Hoh, 2016, CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease, J Neurosurg, 124, 1746, 10.3171/2015.6.JNS15795 Storey, 2007, Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes, J Am Coll Cardiol, 50, 1852, 10.1016/j.jacc.2007.07.058 Johnston, 2016, ticagrelor versus aspirin in acute stroke or transient ischemic attack, N Engl J Med, 375, 35, 10.1056/NEJMoa1603060 Amarenco, 2017, Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial, Lancet Neurol, 16, 301, 10.1016/S1474-4422(17)30038-8 Wang, 2019, Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial, BMJ, 365 Johnston, 2020, Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA, N Engl J Med, 383, 207, 10.1056/NEJMoa1916870 Amarenco, 2020, Ticagrelor added to aspirin in acute nonsevere ischemic stroke or transient ischemic attack of atherosclerotic origin, Stroke, 51, 3504, 10.1161/STROKEAHA.120.032239 Kwon, 2005, Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis, Stroke, 36, 782, 10.1161/01.STR.0000157667.06542.b7 Toyoda, 2019, Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial, Lancet Neurol, 18, 539, 10.1016/S1474-4422(19)30148-6 Uchiyama, 2015, Final results of cilostazol-aspirin therapy against recurrent stroke with intracranial artery stenosis (CATHARSIS), Cerebrovasc Dis Extra, 5, 1, 10.1159/000369610 Kwon, 2011, Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis, Stroke, 42, 2883, 10.1161/STROKEAHA.110.609370 Eikelboom, 2017, Rivaroxaban with or without aspirin in stable cardiovascular disease, N Engl J Med, 377, 1319, 10.1056/NEJMoa1709118 Sharma, 2019, Stroke outcomes in the COMPASS trial, Circulation, 139, 1134, 10.1161/CIRCULATIONAHA.118.035864 2020, Glycemic targets: standards of medical care in diabetes-2020, Diabetes Care, 43, S66 Lee, 2003, Physical activity and stroke risk: a meta-analysis, Stroke, 34, 2475, 10.1161/01.STR.0000091843.02517.9D Kalvach, 2007, Cerebral blood supply with aging: normal, stenotic and recanalized, J Neurol Sci, 257, 143, 10.1016/j.jns.2007.01.056 Rothwell, 2003, Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease, Stroke, 34, 2583, 10.1161/01.STR.0000094424.38761.56 Flemming, 2004, Secondary prevention strategies in ischemic stroke: identification and optimal management of modifiable risk factors, Mayo Clinic Proc, 79, 1330, 10.4065/79.10.1330 Park, 2018, Intensive blood pressure control may not be safe in subacute ischemic stroke by intracranial atherosclerosis: a result of randomized trial, J Hypertens, 36, 1936, 10.1097/HJH.0000000000001784 Amin-Hanjani, 2016, Effect of hemodynamics on stroke risk in symptomatic atherosclerotic vertebrobasilar occlusive disease, JAMA Neurol, 73, 178, 10.1001/jamaneurol.2015.3772 Amin-Hanjani, 2017, Higher stroke risk with lower blood pressure in hemodynamic vertebrobasilar disease: analysis from the VERiTAS study, J Stroke Cerebrovasc Dis, 26, 403, 10.1016/j.jstrokecerebrovasdis.2016.09.044 Amin-Hanjani, 2020, Natural history of hemodynamics in vertebrobasilar disease: temporal changes in the VERiTAS study cohort, Stroke, 51, 3295, 10.1161/STROKEAHA.120.029909 Powers, 2014, Lower stroke risk with lower blood pressure in hemodynamic cerebral ischemia, Neurology, 82, 1027, 10.1212/WNL.0000000000000238 Prabhakaran, 2020, Predictors of early infarct recurrence in patients with symptomatic intracranial atherosclerotic disease, Stroke, 51, A80, 10.1161/str.51.suppl_1.80 Amarenco, 2009, Results of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial by stroke subtypes, Stroke, 40, 1405, 10.1161/STROKEAHA.108.534107 Zhou, 2014, Efficacy and safety of intensive statin therapy in Chinese patients with atherosclerotic intracranial arterial stenosis: a single-center, randomized, single-blind, parallel-group study with one-year follow-up, Clin Neurol Neurosurg, 120, 6, 10.1016/j.clineuro.2014.02.001 Miao, 2019, Intensive lipid-lowering therapy ameliorates asymptomatic intracranial atherosclerosis, Aging Dis, 10, 258, 10.14336/AD.2018.0526 Chung, 2020, Intensive statin treatment in acute ischaemic stroke patients with intracranial atherosclerosis: a high-resolution magnetic resonance imaging study (STAMINA-MRI study), J Neurol Neurosurg Psychiatry, 91, 204, 10.1136/jnnp-2019-320893 Amarenco, 2020, A comparison of two LDL cholesterol targets after ischemic stroke, N Engl J Med, 382, 9, 10.1056/NEJMoa1910355 Chimowitz, 2011, Stenting versus aggressive medical therapy for intracranial arterial stenosis, N Engl J Med, 365, 993, 10.1056/NEJMoa1105335 Miao, 2012, Randomized controlled trial of symptomatic middle cerebral artery stenosis: endovascular versus medical therapy in a Chinese population, Stroke, 43, 3284, 10.1161/STROKEAHA.112.662270 Compter, 2015, Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial, Lancet Neurol, 14, 606, 10.1016/S1474-4422(15)00017-4 Markus, 2017, Stenting for symptomatic vertebral artery stenosis: the vertebral artery ischaemia stenting trial, Neurology, 89, 1229, 10.1212/WNL.0000000000004385 Lutsep, 2015, Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis, Stroke, 46, 775, 10.1161/STROKEAHA.114.007752 Alexander, 2019, WEAVE Trial: final results in 152 on-label patients, Stroke, 50, 889, 10.1161/STROKEAHA.118.023996 Fiorella, 2012, Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS), Stroke, 43, 2682, 10.1161/STROKEAHA.112.661173 Stapleton, 2020, Submaximal angioplasty for symptomatic intracranial atherosclerotic disease: a meta-analysis of peri-procedural and long-term risk, Neurosurgery, 86, 755, 10.1093/neuros/nyz337 1985, Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial, N Engl J Med, 313, 1191, 10.1056/NEJM198511073131904 Baaj, 2009, Surgical management of Moyamoya disease: a review, Neurosurg Focus, 26, E7, 10.3171/2009.01.FOCUS08293 Gonzalez, 2020, Encephaloduroarteriosynangiosis (EDAS) revascularization for symptomatic intracranial atherosclerotic steno-occlusive (ERSIAS) phase-II objective performance criterion trial, Int J Stroke, 16, 701, 10.1177/1747493020967256 Hess, 2015, Remote ischaemic conditioning-a new paradigm of self-protection in the brain, Nat Rev Neurol, 11, 698, 10.1038/nrneurol.2015.223 Meng, 2015, Ischemic conditioning is safe and effective for octo- and nonagenarians in stroke prevention and treatment, Neurotherapeutics, 12, 667, 10.1007/s13311-015-0358-6 Meng, 2012, Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis, Neurology, 79, 1853, 10.1212/WNL.0b013e318271f76a Hou, 2016, Remote limb ischemic conditioning treatment for intracranial atherosclerotic stenosis patients, Int J Stroke, 11, 831, 10.1177/1747493016654489 Ma, 2019, Risk factors for intracranial atherosclerosis: a systematic review and meta-analysis, Atherosclerosis, 281, 71, 10.1016/j.atherosclerosis.2018.12.015 Feng, 2019, Stroke mechanisms in symptomatic intracranial atherosclerotic disease: classification and clinical implications, Stroke, 50, 2692, 10.1161/STROKEAHA.119.025732 Liu, 2017, Comparison of antidiabetic medications during the treatment of atherosclerosis in T2DM patients, Mediators Inflamm, 2017, 10.1155/2017/5032708 Nissen, 2008, Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial, JAMA, 299, 1561, 10.1001/jama.299.13.1561 Wu, 2018, Association between fasting triglyceride levels and the prevalence of asymptomatic intracranial arterial stenosis in a Chinese community-based study, Sci Rep, 8 Hoshino, 2022, Atherogenic dyslipidemia and residual vascular risk after stroke or transient ischemic attack, Stroke, 53, 79, 10.1161/STROKEAHA.121.034593 Shen, 2016, Omega-3 fatty acid supplement prevents development of intracranial atherosclerosis, Neuroscience, 334, 226, 10.1016/j.neuroscience.2016.08.013 Bhatt, 2019, Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia, N Engl J Med, 380, 11, 10.1056/NEJMoa1812792 Vermeer, 2003, Silent brain infarcts and the risk of dementia and cognitive decline, N Engl J Med, 348, 1215, 10.1056/NEJMoa022066 Tardif, 2019, Efficacy and safety of low-dose colchicine after myocardial infarction, N Engl J Med, 381, 2497, 10.1056/NEJMoa1912388 Kelly, 2021, Colchicine for prevention of vascular inflammation in non-cardioembolic stroke (CONVINCE): study protocol for a randomised controlled trial, Eur Stroke J, 6, 222, 10.1177/2396987320972566 Gao, 2015, China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): a new, prospective, multicenter, randomized controlled trial in China, Interv Neuroradiol, 21, 196, 10.1177/1591019915581778